It Starts with One Health: A Guide to Translational Science from Research to Investment

2:30 PM - 4:00 PM, Monday, June 3, 2019 ・ 115B, Level 100
At the heart of One Health—the recognition that the health of humans, animals, and the environment are all interconnected—lies enormous opportunity for researchers, companies, and investors. This observation underpins much of the translational science that is working to improve human, animal, and environmental health. Today’s session features an introductory keynote from a One Health business leader, R.J. Kirk, CEO of Intrexon, followed by an esteemed panel walking us through a series of case studies on the how, the why, the dollars, the cents, behind One Health and translational science.
VP, Global M&A Operations and Divestitures (Pharmaceuticals Group), Global Infectious Diseases & Vaccines Business Development
Johnson & Johnson Innovation
Chief Executive Officer
Medical Officer/Policy Advisor, Office of the Director, NIAID
National Institute of Health
Program Officer - Translational Centers of Excellence and Research Coordination Section Office of Biodefense, Research Resources and Translational Research, DMID/NIAID